Combining vitamin K2 MK-7 with calcium supplements delivers essential benefits to consumers, ensuring calcium is kept moving in arteries and deposited into the bone mass. This delivers a clear point of differentiation in the bone health market.
However, our research shows that MK-7 recovery in consumer products containing both calcium and MK-7 only averaged 42%. Further studies showed that alkalinity, porous surface of certain calcium & tableting stress lead to excessive losses.
Read how Kappa Bioscience’s aim to deliver 100% recovery resulted in the development of a new ingredient standard.